BRIEF

on Aspire Biopharma, Inc. (NASDAQ:PWUP)

Aspire Biopharma Introduces BUZZ BOMB Supplement at Leading Fitness Events

Stock price chart of Aspire Biopharma, Inc. (EBR:PWUP) showing fluctuations.

Aspire Biopharma Holdings, Inc. has announced the launch of BUZZ BOMB™, a sublingual pre-workout supplement, at FitCon and FitExpo, prominent fitness conventions in Salt Lake City and Anaheim. BUZZ BOMB™ offers quick energy through its unique delivery method, delivering 50mg of caffeine directly under the tongue for immediate effect.

This innovative product aims to enhance energy and focus for athletes and fitness enthusiasts, distinguishing itself from traditional pre-workout supplements that require mixing with water. At FitCon, BUZZ BOMB™ will be showcased as a Gold Sponsor, prominently featuring its brand to thousands of attendees. Similarly, at FitExpo, the product will be highlighted with prime booth placement and extensive marketing exposure.

Company representatives will engage visitors with contests and promotions, including face-to-face introductions with influencers. Aspire's CEO, Michael Howe, expressed excitement about the positive feedback received from initial sampling and anticipates expanding market opportunities within the health sector.

R. P.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Aspire Biopharma, Inc. news